<DOC>
	<DOCNO>NCT00741039</DOCNO>
	<brief_summary>Infections due influenza pneumococcus serious cause death . Anyone get infection . However , people great risk disease , include people 65 old , young , people special health problem people certain type cancer , heart , lung , kidney disease , diabetes . Influenza cause serious lung infection ( pneumonia ) increase risk stroke heart attack . Pneumococcal disease lead serious infection lung ( pneumonia ) , blood ( bacteremia ) , cover brain ( meningitis ) . People special health problem mention even likely die disease . Although drug treat infection , always effective . This make prevention disease vaccination even important . This study look body 's response influenza pneumococcal vaccination . We want see well protect . Immunization vaccination . Our goal protect much . We study information need see well old patient cancer respond vaccine well protect disease cause influenza pneumococcus .</brief_summary>
	<brief_title>Prospective Trial Vaccine Responses Against Pneumococcus Influenza Adult Cancer Patients 65 Years Age Older</brief_title>
	<detailed_description />
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Heptavalent Pneumococcal Conjugate Vaccine</mesh_term>
	<criteria>Patient must &gt; = 65 year age . Patient may patient outpatient . Patient must diagnosis prostate , lung , breast cancer . Patient must life expectancy &gt; = 6 month . Patient must Karnofsky score &gt; 40 % Patient must willing return hospital 812 week follow immunization blood work . Patients must platelet count &gt; 75,000 intramuscular injection . Patient may either gender ethnic background . Patients must able understand nature risk propose study able sign consent . Volunteer eligibility : MSKCC employee Age &gt; = 65 year age No previous diagnosis cancer except basal cell carcinoma , resect Stage I melanoma situ cervical carcinoma . Volunteers may prior history cancer &gt; 3 year require local resection , local radiation and/or hormonal therapy androgen blockade . Patients must able understand nature risk propose study able sign consent . Karnofsky score &lt; 40 % : Patients receive autologous allogeneic HCT Active uncontrolled bacterial fungal infection Hypersensitivity egg protein ( eggs egg product ) , chicken protein , component influenza vaccine Prior history lifethreatening reaction previous administration influenza vaccine component thimerosal ( inclusion thimerosal vary among package ) Latex allergy go receive influenza vaccine Ongoing neurologic disorder ( mental status change , uncontrolled seizure , encephalopathy ) Treatment plan treatment cyclophosphamide , ifosphamide , &gt; = 1 mg/kg prednisone equivalent 12 week within 12 week vaccination . HIV1,2 seropositive patient . Patients sign informed consent . Patients receive seasonal influenza vaccine may within 6 month enrollment Healthy control exclusion : Volunteers ineligible receive either vaccine Volunteers unwilling unable sign consent Hypersensitivity egg protein ( eggs egg product ) , chicken protein , component influenza vaccine Latex allergy</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>Breast</keyword>
	<keyword>Lung</keyword>
	<keyword>Prostate</keyword>
	<keyword>Vaccine</keyword>
</DOC>